BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35626711)

  • 1. Metabolomic Profiling in Patients with Heart Failure and Exercise Intolerance: Kynurenine as a Potential Biomarker.
    Bekfani T; Bekhite M; Neugebauer S; Derlien S; Hamadanchi A; Nisser J; Hilse MS; Haase D; Kretzschmar T; Wu MF; Lichtenauer M; Kiehntopf M; von Haehling S; Schlattmann P; Lehmann G; Franz M; Möbius-Winkler S; Schulze C
    Cells; 2022 May; 11(10):. PubMed ID: 35626711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic fingerprint of heart failure with preserved ejection fraction.
    Zordoky BN; Sung MM; Ezekowitz J; Mandal R; Han B; Bjorndahl TC; Bouatra S; Anderson T; Oudit GY; Wishart DS; Dyck JR;
    PLoS One; 2015; 10(5):e0124844. PubMed ID: 26010610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.
    Hunter WG; Kelly JP; McGarrah RW; Khouri MG; Craig D; Haynes C; Ilkayeva O; Stevens RD; Bain JR; Muehlbauer MJ; Newgard CB; Felker GM; Hernandez AF; Velazquez EJ; Kraus WE; Shah SH
    J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of left atrial function with exercise capacity and muscle endurance in patients with heart failure.
    Bekfani T; Hamadanchi A; Ijuin S; Bekhite M; Nisser J; Derlien S; Westphal J; Bogoviku J; Morris DA; Fudim M; Braun-Dullaeus RC; Möbius-Winkler S; Schulze PC
    ESC Heart Fail; 2021 Dec; 8(6):4528-4538. PubMed ID: 34726343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic Profile in HFpEF vs HFrEF Patients.
    Hage C; Löfgren L; Michopoulos F; Nilsson R; Davidsson P; Kumar C; Ekström M; Eriksson MJ; Lyngå P; Persson B; Wallén H; Gan LM; Persson H; Linde C
    J Card Fail; 2020 Dec; 26(12):1050-1059. PubMed ID: 32750486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal Muscle Function, Structure, and Metabolism in Patients With Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction.
    Bekfani T; Bekhite Elsaied M; Derlien S; Nisser J; Westermann M; Nietzsche S; Hamadanchi A; Fröb E; Westphal J; Haase D; Kretzschmar T; Schlattmann P; Smolenski UC; Lichtenauer M; Wernly B; Jirak P; Lehmann G; Möbius-Winkler S; Schulze PC
    Circ Heart Fail; 2020 Dec; 13(12):e007198. PubMed ID: 33302709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction.
    Hahn VS; Petucci C; Kim MS; Bedi KC; Wang H; Mishra S; Koleini N; Yoo EJ; Margulies KB; Arany Z; Kelly DP; Kass DA; Sharma K
    Circulation; 2023 Apr; 147(15):1147-1161. PubMed ID: 36856044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.
    Tromp J; Westenbrink BD; Ouwerkerk W; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Lang CC; Ng LL; Zannad F; Zwinderman AH; Hillege HL; van der Meer P; Voors AA
    J Am Coll Cardiol; 2018 Sep; 72(10):1081-1090. PubMed ID: 30165978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma amino acid metabolomic pattern in heart failure patients with either preserved or reduced ejection fraction: The relation to established risk variables and prognosis.
    Saleem TH; Algowhary M; Kamel FEM; El-Mahdy RI
    Biomed Chromatogr; 2021 Jul; 35(7):e5012. PubMed ID: 33119901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial factors, mental health, and coordination capacity in patients with heart failure with preserved ejection fraction compared with heart failure with reduced ejection fraction.
    Bekfani T; Nisser J; Derlien S; Hamadanchi A; Fröb E; Dannberg G; Lichtenauer M; Smolenski UC; Lehmann G; Möbius-Winkler S; Schulze PC
    ESC Heart Fail; 2021 Aug; 8(4):3268-3278. PubMed ID: 34121363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-Skeletal Abnormalities and Muscle Oxygenation during Isokinetic Strength Exercise in Heart Failure with Preserved Ejection Fraction Phenotype: A Cross-Sectional Study.
    Vale-Lira A; Turri-Silva N; Verboven K; Durigan JLQ; de Lima ACGB; Bottaro M; Chiappa GR; Hansen D; Cipriano G
    Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological dead space and arterial carbon dioxide contributions to exercise ventilatory inefficiency in patients with reduced or preserved ejection fraction heart failure.
    Van Iterson EH; Johnson BD; Borlaug BA; Olson TP
    Eur J Heart Fail; 2017 Dec; 19(12):1675-1685. PubMed ID: 28990307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study.
    Eidizadeh A; Schnelle M; Leha A; Edelmann F; Nolte K; Werhahn SM; Binder L; Wachter R
    ESC Heart Fail; 2023 Feb; 10(1):200-210. PubMed ID: 36184749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle alterations in HFrEF vs. HFpEF.
    Adams V; Linke A; Winzer E
    Curr Heart Fail Rep; 2017 Dec; 14(6):489-497. PubMed ID: 28940089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
    ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of combined cardiopulmonary and echocardiography stress test to characterize the haemodynamic and metabolic responses of patients with heart failure and mid-range ejection fraction.
    Pugliese NR; Fabiani I; Santini C; Rovai I; Pedrinelli R; Natali A; Dini FL
    Eur Heart J Cardiovasc Imaging; 2019 Jul; 20(7):828-836. PubMed ID: 30753369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction.
    Tromp J; Khan MAF; Mentz RJ; O'Connor CM; Metra M; Dittrich HC; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JGF; Givertz MM; Bloomfield DM; Van Veldhuisen DJ; Hillege HL; Voors AA; van der Meer P
    JACC Heart Fail; 2017 Jul; 5(7):507-517. PubMed ID: 28624483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics of 547 new onset heart failure patients in the PREFERS heart failure study.
    Linde C; Ekström M; Eriksson MJ; Maret E; Wallén H; Lyngå P; Wedén U; Cabrera C; Löfström U; Stenudd J; Lund LH; Persson B; Persson H; Hage C;
    ESC Heart Fail; 2022 Aug; 9(4):2125-2138. PubMed ID: 35403374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
    Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.